Bayview Pharmacy is pleased to provide Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine), a compounded formulation designed specifically for the treatment of various equine conditions such as Cushing's Disease, Equine Pituitary Pars Intermedia Dysfunction, Hyperadrenocorticism, Hyperinsulinemia, and Equine Metabolic Syndrome. Pergolide, a dopamine agonist, functions by reducing the production of hormones that trigger these conditions, making it an effective and safe treatment option for horses afflicted with these diseases.

This medication is a liquid dosage form in which one or more ingredients are uniformly dispersed throughout a liquid medium, creating a homogeneous mixture for administration. Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) is administered orally, typically once a day. The dosage and duration of treatment are determined by the severity of the condition and the horse's response to treatment. It is crucial to adhere to your veterinarian's instructions and to closely monitor your horse's reaction to the medication.

If you have any inquiries about Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) or any other compounded medications, please do not hesitate to contact us at Bayview Pharmacy. Our primary goal is to assist you and your horse in receiving the most effective treatment possible. We are here to provide support and answer any questions you may have regarding your horse's medication and treatment plan.

This compounded formulation of Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) is a liquid dosage form that provides a homogeneous mixture for administration. It is specifically designed for the treatment of various equine conditions such as Cushing's Disease, Equine Pituitary Pars Intermedia Dysfunction, Hyperadrenocorticism, Hyperinsulinemia, and Equine Metabolic Syndrome. The active ingredient, Pergolide, is a dopamine agonist that functions by inhibiting the release of hormones from the pituitary gland. This action helps to alleviate the symptoms associated with these conditions.

It is crucial to be aware that Pergolide should not be administered to horses with a known hypersensitivity to the drug or any of its components. It is also contraindicated in horses with hepatic or renal impairment. The horse's response to the medication should be closely monitored, and the dose should be adjusted as necessary to ensure optimal therapeutic outcomes. If there are any questions or concerns regarding this formulation or its use, we encourage you to contact us for further information.

Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) is a compounded formulation designed specifically for the treatment of various equine conditions such as Cushing's Disease, Equine Pituitary Pars Intermedia Dysfunction, Hyperadrenocorticism, Hyperinsulinemia, and Equine Metabolic Syndrome. This oral medication functions by inhibiting the release of hormones from the pituitary gland, thereby alleviating the symptoms associated with these disorders.

The medication is typically administered once daily, although the dosage may require adjustment based on the individual horse's response to the treatment. It is crucial to closely observe the horse's reaction to the medication and modify the dosage as necessary. The most common side effects observed with pergolide use include a decrease in appetite, weight loss, and an increase in thirst. If any of these side effects are noted, it is essential to immediately contact your veterinarian for advice.

Adherence to the instructions provided by your veterinarian when administering this medication is of utmost importance to ensure its effectiveness and the safety of your horse. If you have any queries or concerns regarding this formulation or its mechanism of action, please do not hesitate to contact us for further information.

The Pergolide 1 mg/5 ml Oral Suspension (Vet-Equine) is a compounded formulation specifically designed for the treatment of various equine conditions. These include Cushing's Disease, Equine Pituitary Pars Intermedia Dysfunction, Hyperadrenocorticism, Hyperinsulinemia, and Equine Metabolic Syndrome. It is also utilized to mitigate the risk of laminitis in horses diagnosed with Cushing's Disease.

This formulation is presented in a liquid dosage form, ensuring a uniform dispersion of the active ingredient, Pergolide, throughout the liquid medium. This provides a homogeneous mixture for easy and accurate administration. The product is packaged in a 5 ml bottle for convenience and precision.

The recommended dosage for this formulation is 0.1 mg/kg body weight, administered once daily. It is crucial to administer this medication orally, as per the prescribed dosage, to ensure its effectiveness.

However, it is important to exercise caution while using this formulation. It is not recommended for horses with known hypersensitivity to pergolide or any other ingredients present in the formulation. Furthermore, it should not be administered to horses with hepatic or renal impairment, as it may exacerbate their condition.

If you have any queries or require further information regarding the use of this formulation, please do not hesitate to contact us. We are here to assist you in providing the best possible care for your equine companions.